Abstract:Owing to the complexity of interacting molecular networks on the cell surface, integrin-associated tetraspanin CD151 remains controversial regarding its clinical importance and functional impact in prostate cancer. The current study evaluated dynamics and clinical importance of CD151 expression and its function in prostate cancer by IHC analysis of two independent patient cohorts (n=80, 181), bioinformatic interrogation of the TCGA database, and evaluation of gene knockdown effect at the cellular level. Our data showed that aside from high mRNA expression, CD151 was primarily localized to intercellular junctions at the plasma membrane in normal prostate glands or benign tissues, regardless of nature of antibodies used. By contrast, in primary tumors from patients with metastatic disease, CD151 was largely localized in the cytosol. Furthermore, the level of the cell-cell junction-linked CD151 was inversely associated with Gleason grade and tumor stage (P<0.001 for both). The portion of primary tumors expressing junctional CD151 was also three-fold less in the metastatic patient population than its counterpart (P<0.001). In line with these observations, CD151 and its associated α3β1 or α6β4 integrin inversely correlated with androgen receptor (AR) at the mRNA level (Spearman coefficient: -0.44, -0.48 and -0.42) in the TCGA cohort. Expression of these adhesion molecules also correlated with DNA methylation in their promoters (Spearman coefficient: -0.37, -0.71 and -0.82). Combined, these data suggest that CD151 and associated integrins are linked to tumor metastasis through AR and the epigenetic program. Meanwhile, CD151 knockdown in E-cadherin-positive tumor cells led to increased cell proliferation and induction of the epithelial-mesenchymal transition (EMT)-like phenotype. Given the strong RGD-binding integrin dependence of EMT-featured tumor cells, we examined focal adhesion kinase (FAK), their key signaling effector, in the above patient cohorts. In contrast to CD151, FAK exhibited positive correlation with tumor grade and stage as well as AR and p53 inactivation at either mRNA, protein or genomic level. Taken together, our results suggest that CD151 represses prostate cancer by antagonizing cell proliferation, EMT and the signaling of RGD-binding integrins. Since this anti-tumorigenic role is prone to the AR-mediated transcriptional and epigenetic regulation, CD151 and possibly α3β1 and α6β4 integrins are of potential biomarkers for metastatic prostate cancer.

CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer

Integrin-associated CD151 Drives ErbB2-evoked Mammary Tumor Onset and Metastasis.

The Expression of PETA-3/CD151 in Non-Small Cell Lung Carcinoma and Its Clinical Significance

Cd151 Promotes Colorectal Cancer Progression By A Crosstalk Involving Ceacam6, Lgr5 And Wnt Signaling Via Tgf Beta 1

CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1

Integrin beta1 over-expression associates with resistance to tyrosine kinase inhibitor gefitinib in non-small cell lung cancer.

Integrin beta 1 enhances the epithelial-mesenchymal transition in association with gefitinib resistance of non-small cell lung cancer.

The Role of Up-Regulation of Integrin Β1 in Resistance to Gefitinib in Non-Small Cell Lung Cancer

Beta 1 Integrin Mediated Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Lung Cancer Cells

Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer

CD151 Promotes Cell Metastasis Via Activating TGF-β1/Smad Signaling in Renal Cell Carcinoma

Integrin-associated CD151 is a Suppressor of Prostate Cancer Progression

Deletion of Tetraspanin CD151 Alters the Wnt Oncogene-Induced Mammary Tumorigenesis: A Cell Type-Linked Function and Signaling.

CD151 Modulates Expression of Matrix Metalloproteinase 9 and Promotes Neoangiogenesis and Progression of Hepatocellular Carcinoma

CD151 Amplifies Signaling by Integrin Α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells

CXCR4 is Involved in CD133-induced EMT in Non-Small Cell Lung Cancer.

CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis.

Integrin Α3/α6 and Αv Are Implicated in ADAM15-activated FAK and EGFR Signalling Pathway Individually and Promote Non-Small-cell Lung Cancer Progression

Profiling of the Tetraspanin CD151 Web and Conspiracy of CD151/integrin Β1 Complex in the Progression of Hepatocellular Carcinoma.

Integrin beta 3 Promotes Resistance to EGFR-TKI in Non-Small-Cell Lung Cancer by Upregulating AXL through the YAP Pathway